UBS AG - Listing of UBS Autocallable Note linked to the SD3E and the HSI Index

Listing of UBS Autocallable Note linked to the SD3E and the HSI Index

UBS AG, London Branch
("UBS AG" or the "Company")
(Incorporated and domiciled in Switzerland)
(Registration number: CHE-101.329.561)

Listing of UBS Autocallable Note linked to the SD3E and the HSI Index (the
"Notes") – Series 10.

The JSE Limited has granted UBS approval for the listing of the Autocallable
Note linked to the EURO STOXX® Select Dividend 30 (Price) Index and the Hang
Seng Index due 11 November 2030.

An autocallable is a structured product which pays investors return payments,
subject to an underlying reference asset(s) being at or above a specified
level. The products have a fixed maximum tenor; however, the tenor may be
shorter if the product is called. The product has set observation dates on
which the return payments are made, and the product can be called early. The
return paid by the product is financed by a short position in a put option.
The put option has a tenor that matches the maximum tenor of the product.

The Notes are a notional rand denominated structured product referencing
global indices. This product offers a return if on any Observation Date all
Underlyings close at or above the Autocall Barrier level. In this case, the
investor will receive a fixed payment for every observation period that has
passed since inception. The product also allows for early redemption before
expiry, with the investor receiving back their invested capital on top of
the relevant return for the relevant period if all Underlyings close at or
above a specific Autocall Barrier level on any Early Termination Observation
Date.

If no autocall event occurs, the investor will receive 100% of the Nominal
on the Redemption Date provided none of the Knock-In Levels have been breached
on the Expiration Date.

If at least one of the Underlyings closes below its respective Knock-In Level
at expiry, the redemption value will reflect the performance of the worst
performing Underlying.

This listing is issued under the Information Memorandum of UBS AG. Trading
will commence on Wednesday, 20 November 2024.

INSTRUMENT NUMBER:           118462
ALPHA CODE:                  UBGPAG
ISIN:                        ZAE000341103
ISSUE SIZE (UNITS):          200,000 (unit quotation)
ISSUE PRICE (RAND):          1,000 per Note

UNDERLYING INDICES:          EURO STOXX® Select Dividend 30 (Price) Index
                             (Bloomberg: SD3E Index) ("Index 1")

                             Hang Seng Index
                             (Bloomberg: HSI Index) ("Index 2")

LISTING DATE:                20 November 2024
EXPIRY DATE:                 11 November 2030

Underlyings and Levels (on Pricing Date):
 Index       Initial        Contingent    Mandatory Early        Knock-In
               Level      Coupon Level Termination Level            Level
               Index       100% of the 100% of the Index       70% of the
             Closing     Index Closing      Closing Level   Index Closing
               Level             Level                              Level
 SD3E      1,626.860         1,626.860          1,626.860       1,138.802
 HSI      20,538.380        20,538.380         20,538.380      14,376.866

Observation Date(s):

n    Date
1    N/A
2    09 November 2026
3    08 November 2027
4    06 November 2028
5    12 November 2029
6    11 November 2030

Early Termination Observation Date(s):

n    Date
1    N/A
2    09 November 2026
3    08 November 2027
4    06 November 2028
5    12 November 2029
6    11 November 2030

For further information kindly contact:

UBS KeyInvest South Africa
Tel.: +27 11 322 7129 / 7317
E-mail: keyinvestza@ubs.com
Web: http://keyinvest-za.ubs.com/products

Johannesburg
19 November 2024

Sponsor: UBS South Africa (Pty) Limited

Date: 19-11-2024 02:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.